From Our Thought Leaders

Incannex Healthcare Advances Cannabinoid Therapies Through Clinical and Regulatory Development

  The development of cannabinoid and psychedelic medicines is entering a more evidence-driven phase, with clinical validation, safety, regulatory alignment and patient outcomes becoming increasingly important to their potential adoption. For ... Read more

01 September, 2026 | Tuesday | Interaction
CurTec Drives Sustainable Packaging Innovation for Biopharma Supply Chains

At INTERPHEX, sustainability and supply chain performance emerged as important priorities for pharmaceutical packaging. John Jansen, Head of Global Marketing and Intelligence at CurTec, discusses how packaging manufacturers can reduce material use an... Read more

28 August, 2026 | Friday | Expert Opinion
QT Imaging Advances Quantitative Breast Imaging With 3D, Radiation-Free Ultrasound

  As breast imaging continues to evolve toward more quantitative and patient-centred approaches, QT Imaging is developing a three-dimensional ultrasound platform designed to provide detailed breast imaging without ionising radiation, compressio... Read more

25 August, 2026 | Tuesday | Interview
Quotient Sciences on How AI Is Reshaping the CDMO–Sponsor Relationship

    As AI and digital technologies increasingly influence pharmaceutical development, CDMOs are taking on a broader role in helping sponsors improve efficiency, manage risk and accelerate development timelines. In this interview, Matt Pat... Read more

25 August, 2026 | Tuesday | Interaction

Bio Finance

HCW Biologics Secures U.S. Patent Allowance for HCW9302 in Alopecia Areata

HCW Biologics Inc. (the “Company” or “HCW Biologics”), a U.S.-based clinical-stage biopharmaceutical company focused on developing novel fusion immunotherapeutics to treat autoimmune diseases, cancer, and senescence-associat... Read more

04 September, 2026 | Friday | News
Eisai and Biogen Launch Weekly Subcutaneous LEQEMBI IQLIK for Early Alzheimer’s in the U.S.

Eisai Co., Ltd. and Biogen Inc., announced that once weekly lecanemab-irmb subcutaneous injection (brand name: LEQEMBI IQLIK®) is now available in the U.S. for initiation therapy for early Alzheimer’s disease (AD) in adults with mild cogn... Read more

26 August, 2026 | Wednesday | News

Contract Services

Quotient Sciences on How AI Is Reshaping the CDMO–Sponsor Relationship

    As AI and digital technologies increasingly influence pharmaceutical development, CDMOs are taking on a broader role in helping sponsors improve efficiency, manage risk and accelerate development timelines. In this interview, Matt Pat... Read more

25 August, 2026 | Tuesday | Interaction
PacBio Boosts Vega HiFi Sequencing Output by 50% with New SPRQ-Nx Chemistry

PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, announced the upcoming availability of SPRQ-Nx chemistry and an accompanying software update for its Vega systems. Together, the updates expand the range o... Read more

13 August, 2026 | Thursday | News

BioPharma Video

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close